contexttherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# Squarespace Robots Txt User-agent: AdsBot-Google Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* Disallow:/*&tag=* Disallow:/*?month=* Disallow:/*&month=* Disallow:/*?view=* Disallow:/*&view=* Disallow:/*?format=json Disallow:/*&format=json Disallow:/*?format=page-context Disallow:/*&format=page-context Disallow:/*?format=main-content Disallow:/*&format=main-content Disallow:/*?format=json-pretty Disallow:/*&format=json-pretty Disallow:/*?format=ical Disallow:/*&format=ical Disallow:/*?reversePaginate=* Disallow:/*&reversePaginate=* User-agent: AdsBot-Google-Mobile Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* | ||
Meta Tags
| Title | Context |
| Description | Advancing medicines for solid Context Therapeutics is advancing medicines for female |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.185.159.144 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
contexttherapeutics.com Valuation
|
US$19,386,130
Last updated: 2023-05-09 04:08:15
contexttherapeutics.com has Semrush global rank of 545,973. contexttherapeutics.com has an estimated worth of US$ 19,386,130, based on its estimated Ads revenue. contexttherapeutics.com receives approximately 2,236,862 unique visitors each day. Its web server is located in United States, with IP address 198.185.159.144. According to SiteAdvisor, contexttherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$19,386,130 |
| Daily Ads Revenue | US$17,895 |
| Monthly Ads Revenue | US$536,847 |
| Yearly Ads Revenue | US$6,442,160 |
| Daily Unique Visitors | 149,125 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| contexttherapeutics.com. 600 | A | contexttherapeutics.com. 600 | IP: 198.185.159.144 |
| contexttherapeutics.com. 600 | A | contexttherapeutics.com. 600 | IP: 198.185.159.145 |
| contexttherapeutics.com. 600 | A | contexttherapeutics.com. 600 | IP: 198.49.23.144 |
| contexttherapeutics.com. 600 | A | contexttherapeutics.com. 600 | IP: 198.49.23.145 |
| contexttherapeutics.com. 3600 | NS | contexttherapeutics.com. 3600 | NS Record: ns04.domaincontrol.com. |
| contexttherapeutics.com. 3600 | NS | contexttherapeutics.com. 3600 | NS Record: ns03.domaincontrol.com. |
| contexttherapeutics.com. 3600 | MX | contexttherapeutics.com. 3600 | MX Record: 0 contexttherapeutics-com.mail.protection.outlook.com. |
| contexttherapeutics.com. 3600 | TXT | contexttherapeutics.com. 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-09 04:08:15
| About Science Pipeline Investors & News About Science Pipeline Investors & News Scroll Advancing medicines for solid tumors Our Vision Context is dedicated to developing the next generation of therapies to treat solid tumors. We are advancing CTIM-76, an investigational anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody for CLDN6-positive tumors. CTIM-76 is intended to redirect T-cell mediated lysis toward malignant cells expressing CLDN6. Pipeline IND Enabling Phase 1 Phase 2 CTIM-76 CLDN6-positive Solid Tumors ONA-XR Exploring strategic options Banner Our Science Overview About Us Leadership Partnering Contact Us Science Pipeline CTIM-76 ONA-XR Publications Patients Investigator Led Trials Access Policy Female Cancers Gynecologic Cancer Breast Cancer Careers Open Positions Our Values Investors & Media News Privacy Policy Terms of Use © Context Therapeutics Inc. 2023 | All Rights Reserved Context Therapeutics 2001 Market Street - Unit 15, Philadelphia, PA, 19103, United States |
HTTP Headers
HTTP/1.1 301 Moved Permanently Age: 127556 Date: Fri, 29 Oct 2021 18:31:56 GMT Location: https://www.contexttherapeutics.com/ Server: Squarespace Set-Cookie: crumb=BUE9xIGEbCo8OTg4NjM1YWY5NGFjYmJlNTkxMjIxM2JiNzQ0MTlk;Path=/ X-Contextid: yElzVa22/WGt3dOiN HTTP/2 200 accept-ranges: bytes age: 146697 content-type: text/html;charset=utf-8 date: Fri, 29 Oct 2021 13:12:55 GMT etag: W/"de07faf01f75f057da7a765558d4fdc3" expires: Thu, 01 Jan 1970 00:00:00 GMT server: Squarespace set-cookie: crumb=BYJIb6dgRK7aMWE0MDUzMjUzMzY5YTkwZjM1ODQ1NGM3NTA4YmU4;Path=/ strict-transport-security: max-age=43200 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: KGeMuKU0/5GWj4CPx content-length: 19092 |
contexttherapeutics.com Whois Information
Domain Name: CONTEXTTHERAPEUTICS.COM Registry Domain ID: 1883292159_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-11-03T17:42:37Z Creation Date: 2014-11-02T16:27:53Z Registry Expiry Date: 2021-11-02T16:27:53Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS03.DOMAINCONTROL.COM Name Server: NS04.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T15:58:44Z <<< |